ClinicalTrials.Veeva

Menu

Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement

H

Hippocration General Hospital

Status and phase

Completed
Phase 2
Phase 1

Conditions

Prevention of Anemia

Treatments

Drug: Iron

Study type

Interventional

Funder types

Other

Identifiers

NCT02957643
HippokratioGH

Details and patient eligibility

About

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment.

Full description

The purpose of the study is to investigate the effectiveness of iron in the treatment of iron deficiency in pregnant 2nd and 3rd quarter. Every 30 days the investigators measure the hemoglobin, hematocrit and iron in serum and assess the course of treatment

Enrollment

50 patients

Sex

Female

Ages

18 to 45 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Age more or equal of 18 years
  2. Registration consent
  3. Have complete 12h week of pregnancy
  4. Hemoglobin levels <10,5 ptl
  5. Hematocrit < 32 %

Exclusion criteria

  1. Age <18 years
  2. Absent registration consent
  3. Step of pregnancy less than 12 weeks
  4. Coadministration formulations iron oral or parenterally
  5. Background of liver kirrosis
  6. Background of aimosidirosis
  7. Background acquired or chronic aimatochromatosis
  8. Aplastic , Hemolytic anemia and chronic diseases
  9. Chronic pancreatitis
  10. Subjective renal or/and liver disease
  11. Hypothyroidism or yperthyreoeidismos

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

50 participants in 2 patient groups, including a placebo group

pregnant women
Placebo Comparator group
Description:
iron dosage 1 per day for 3 months
Treatment:
Drug: Iron
pregnant women with anemia
Experimental group
Description:
iron dosage 1 per day for 6 months
Treatment:
Drug: Iron

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems